Mironid
PrivateLast Round
Series B
Aug 5, 2026
Total Funding Raised
$90.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mironid is a biopharmaceutical company developing small molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mironid Comparables
Compare Mironid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renasant Bio | 80% | |
| Novartis | 76% | |
| xCystence Bio | 76% | |
Mironid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 5, 2026 | ||||
| Series A Extension | Sep 13, 2023 | ||||
| Series A | Jun 20, 2016 |
Mironid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series B, Series A Extension, Series A |
| Epidarex Capital | Series B, Series A Extension, Series A |
| European Investment Fund | Series A Extension, Series A |
| Scottish National Investment Bank | Series B |
| Sofinnova Partners | Series B, Series A Extension, Series A |
| University of Strathclyde | Series B, Series A Extension, Series A |
| BioGeneration Ventures | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
$46M round with participation from BioGeneration Ventures and Epidarex Capital.
- Jun 19, 2026
Monthly visitors increased 58% MoM.
Mironid Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mironid's valuation, stock price, and market status.